This is expected, given that HRDetect was trained on genomes from patients with BRCA1/BRCA2 LOF in breast cancer, whereas NBN plays a role further upstream of BRCA1/BRCA2 in the repair of DNA double-strand breaks12,23. This evidence concerns the gene BRCA2 and breast carcinoma.